Janus Henderson Group’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,843,286
| Closed | -$3.36M | – | 2536 |
|
|
2024
Q3 | $3.36M | Sell |
1,843,286
-3,373,056
| -65% | -$6.16M | ﹤0.01% | 1056 |
|
|
2024
Q2 | $5.76M | Sell |
5,216,342
-1,276,558
| -20% | -$1.41M | ﹤0.01% | 797 |
|
|
2024
Q1 | $12.8M | Sell |
6,492,900
-54,331
| -0.8% | -$107K | 0.01% | 642 |
|
|
2023
Q4 | $10.2M | Sell |
6,547,231
-113,407
| -2% | -$176K | 0.01% | 666 |
|
|
2023
Q3 | $13.1M | Buy |
6,660,638
+441,897
| +7% | +$868K | 0.01% | 610 |
|
|
2023
Q2 | $19.7M | Buy |
6,218,741
+214,268
| +4% | +$679K | 0.01% | 560 |
|
|
2023
Q1 | $19.6M | Buy |
6,004,473
+65,183
| +1% | +$213K | 0.01% | 583 |
|
|
2022
Q4 | $29.8M | Sell |
5,939,290
-1,106,670
| -16% | -$5.55M | 0.02% | 484 |
|
|
2022
Q3 | $16.1M | Buy |
7,045,960
+3,698,789
| +111% | +$8.47M | 0.01% | 721 |
|
|
2022
Q2 | $8.8M | Buy |
3,347,171
+153,877
| +5% | +$405K | 0.01% | 718 |
|
|
2022
Q1 | $4.33M | Buy |
3,193,294
+1,720,683
| +117% | +$2.33M | ﹤0.01% | 1041 |
|
|
2021
Q4 | $4.7M | Buy |
+1,472,611
| New | +$4.7M | ﹤0.01% | 1078 |
|